Cidara Therapeutics (CDTX) Reports Q4 Loss of $0.88/Share

Cidara Therapeutics (NASDAQ: CDTX) reported Q4 EPS of ($0.88), versus ($0.72) reported last year. Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Cidara Therapeutics (CDTX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
• Benchmark Reiterates Buy Rating on Kura Sushi USA Inc. (KRUS) Ahead of Q3 Print